Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,158 | 167,852 | 92,447 | 86,061 | 114,633 |
| Receivables | 132,352 | 140,190 | 118,980 | 107,746 | 81,294 |
| Inventories | 104,209 | 105,124 | 108,539 | 114,466 | 99,322 |
| Other current assets | 6,023 | 4,496 | 4,408 | 5,380 | 4,815 |
| TOTAL | $459,461 | $462,570 | $360,464 | $342,595 | $318,778 |
| Non-Current Assets | |||||
| PPE Net | 311 | 338 | 175 | 201 | 228 |
| Intangibles | 56 | 56 | 56 | 56 | 56 |
| Other Non-Current Assets | 2,701 | 2,922 | 3,325 | 4,233 | 4,967 |
| TOTAL | $3,068 | $3,316 | $3,556 | $4,490 | $5,251 |
| Total Assets | $462,529 | $465,886 | $364,020 | $347,085 | $324,029 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 68,406 | 65,068 | 77,513 | 74,704 | 71,994 |
| Accrued Expenses | 88,488 | 92,318 | 80,127 | 62,508 | 63,076 |
| Other current liabilities | 80,746 | 87,596 | 94,826 | 66,312 | 57,237 |
| TOTAL | $300,359 | $300,810 | $359,033 | $298,796 | $270,966 |
| Non-Current Liabilities | |||||
| Long Term Debt | 152,674 | 152,219 | 151,653 | 146,452 | 141,449 |
| Deferred Revenues | 43,531 | 34,477 | 30,679 | 22,313 | 4,542 |
| Other Non-Current Liabilities | 317,427 | 314,822 | 304,695 | 335,346 | 337,825 |
| TOTAL | $470,101 | $467,041 | $456,348 | $481,798 | $479,274 |
| Total Liabilities | $770,460 | $767,851 | $815,381 | $780,594 | $750,240 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 257,432 | 256,811 | 239,063 | 201,623 | 198,200 |
| Common Shares | 257 | 245 | 205 | 200 | 197 |
| Retained earnings | -1,648,907 | -1,623,711 | -1,685,542 | -1,654,209 | -1,641,484 |
| Other shareholders' equity | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $-307,931 | $-301,965 | $-451,361 | $-433,509 | $-426,211 |
| Total Liabilities And Equity | $462,529 | $465,886 | $364,020 | $347,085 | $324,029 |